Benjamin is a business-minded and purpose driven leader in the pharmaceutical industry with a strong scientific background and cross-cultural experience. Through leadership roles and project assignments, he has gained experience across the pharmaceutical industry value chain and in all phases of drug discovery and development in multiple therapeutic areas.

Benjamin is currently Vice President of Translational Research in Research & Early Development at Novo Nordisk. His area covers biomarker discovery, qualification and assay development, and molecular imaging. Benjamin also represents Global Translational in Research & Early Development committees. Previously, he was Head of Translational Sciences, Head of Translational Medicine & Clinical Pharmacology Respiratory and Head of US Pharmacometrics at Boehringer Ingelheim. 

Benjamin holds a Professional Degree in Pharmacy from University of Tuebingen, a Master of Statistics from University of Florida, an Executive Master of Business Administration from Quantic School of Business and Technology and a PhD in Pharmaceutical Sciences from University of Florida.

His transferable skills include navigating through complex and uncertain situations with calmness and the right sense of urgency, developing and leading individuals and groups, as well as developing and executing strategies in the pharmaceutical industry.

Benjamin was recognized with outstanding young alumni award “40 Gators Under 40” by the University of Florida. He published multiple articles in peer-reviewed journals and received invitations to present at academic institutions and international conferences. 

He has a successful track record of applying situational leadership principles with direct reports and in a matrix environment. Benjamin is strongly convinced and a role model that a healthy work-life-balance is key for sustainable career success.